VeriMomVeriMom
HIGH RISK

임신 중 acrylamide/ sodium acryloyldimethyltaurate copolymer을 피해야 할까요? | VeriMom

Harmonised CLP and ECHA list acrylamide (CAS 79-06-1) as Carc. 1B (H350), Muta.1B (H340) and Repr.2 (H361f), which justifies a suspected reproductive/carcinogenic hazard for the acrylamide monomer. Regulatory and safety reviews (CIR) treat acrylamide‑containing polymers as acceptable only if residual monomer is controlled (e.g., ≤0.1 mg/kg for leave‑on in EU), so mechanism evidence and animal reproductive findings support m=2 and a measurable but low dermal exposure for cosmetics (e=1). (Sources: ECHA harmonised classification; CIR safety assessments; EU Annex III restriction).

ECHA regulatory hazard statements

  • H350
  • H361F

What to use instead

Pregnancy-safe ingredients that serve a similar function:

FAQ

acrylamide/ sodium acryloyldimethyltaurate copolymer은 임신 중 안전한가요?
Harmonised CLP and ECHA list acrylamide (CAS 79-06-1) as Carc. 1B (H350), Muta.1B (H340) and Repr.2 (H361f), which justifies a suspected reproductive/carcinogenic hazard for the acrylamide monomer. Regulatory and safety reviews (CIR) treat acrylamide‑containing polymers as acceptable only if residual monomer is controlled (e.g., ≤0.1 mg/kg for leave‑on in EU), so mechanism evidence and animal reproductive findings support m=2 and a measurable but low dermal exposure for cosmetics (e=1). (Sources: ECHA harmonised classification; CIR safety assessments; EU Annex III restriction).
acrylamide/ sodium acryloyldimethyltaurate copolymer은 모유 수유 중 안전한가요?
Same basis as pregnancy: the hazard derives from acrylamide monomer (harmonised classification and animal data). For topical cosmetic use of the polymer, exposure to acrylamide is low when residual monomer is controlled to regulatory limits, but measurable exposures have been reported in products; therefore a conservative suspected hazard (h=2), demonstrated mechanism (m=2) and low but measurable exposure (e=1) are retained.
acrylamide/ sodium acryloyldimethyltaurate copolymer은 아기 피부에 안전한가요?
Hazard and mechanism remain tied to acrylamide monomer. Because infant skin has higher permeability and surface‑area‑to‑weight, exposure score is increased by +1 relative to adult topical use (adult e=1 → infant e=2), while h and m are unchanged absent infant‑specific toxicology showing different effects. Regulatory residual limits still apply; if residuals are not controlled, infant exposure concern increases.
VeriMom은 acrylamide/ sodium acryloyldimethyltaurate copolymer을 어떻게 평가하나요?
VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 acrylamide/ sodium acryloyldimethyltaurate copolymer을 20/100 (높은 위험)로 평가합니다.
임신 중 acrylamide/ sodium acryloyldimethyltaurate copolymer 대체 안전 성분은?
유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.

모든 성분표를 2초 만에 확인

VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.

의료 면책 조항

이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.

VeriMom 앱에서 모든 기능을 이용해 보세요